<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2002-11-01" modified="2020-10-07" version="167">
<accession>Q9UKT4</accession>
<accession>B3KNX5</accession>
<accession>Q5TF47</accession>
<accession>Q8WV29</accession>
<accession>Q9UGC8</accession>
<name>FBX5_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="26">F-box only protein 5</fullName>
</recommendedName>
<alternativeName>
<fullName evidence="25">Early mitotic inhibitor 1</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary" evidence="27">FBXO5</name>
<name type="synonym" evidence="23">EMI1</name>
<name type="synonym" evidence="27">FBX5</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1999" name="Curr. Biol." volume="9" first="1177" last="1179">
<title>Identification of a family of human F-box proteins.</title>
<authorList>
<person name="Cenciarelli C."/>
<person name="Chiaur D.S."/>
<person name="Guardavaccaro D."/>
<person name="Parks W."/>
<person name="Vidal M."/>
<person name="Pagano M."/>
</authorList>
<dbReference type="PubMed" id="10531035"/>
<dbReference type="DOI" id="10.1016/s0960-9822(00)80020-2"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2002" name="Nat. Cell Biol." volume="4" first="358" last="366">
<title>E2F-dependent accumulation of hEmi1 regulates S phase entry by inhibiting APC(Cdh1).</title>
<authorList>
<person name="Hsu J.Y."/>
<person name="Reimann J.D.R."/>
<person name="Sorensen C.S."/>
<person name="Lukas J."/>
<person name="Jackson P.K."/>
</authorList>
<dbReference type="PubMed" id="11988738"/>
<dbReference type="DOI" id="10.1038/ncb785"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH FZR1 AND CDC20</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>DEVELOPMENTAL STAGE</scope>
<scope>INDUCTION</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<scope>VARIANT GLU-107</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2003" name="Nature" volume="425" first="805" last="811">
<title>The DNA sequence and analysis of human chromosome 6.</title>
<authorList>
<person name="Mungall A.J."/>
<person name="Palmer S.A."/>
<person name="Sims S.K."/>
<person name="Edwards C.A."/>
<person name="Ashurst J.L."/>
<person name="Wilming L."/>
<person name="Jones M.C."/>
<person name="Horton R."/>
<person name="Hunt S.E."/>
<person name="Scott C.E."/>
<person name="Gilbert J.G.R."/>
<person name="Clamp M.E."/>
<person name="Bethel G."/>
<person name="Milne S."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Andrews T.D."/>
<person name="Ashwell R.I.S."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Banerjee R."/>
<person name="Barker D.J."/>
<person name="Barlow K.F."/>
<person name="Bates K."/>
<person name="Beare D.M."/>
<person name="Beasley H."/>
<person name="Beasley O."/>
<person name="Bird C.P."/>
<person name="Blakey S.E."/>
<person name="Bray-Allen S."/>
<person name="Brook J."/>
<person name="Brown A.J."/>
<person name="Brown J.Y."/>
<person name="Burford D.C."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Carder C."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clark G."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Cobley V."/>
<person name="Collier R.E."/>
<person name="Collins J.E."/>
<person name="Colman L.K."/>
<person name="Corby N.R."/>
<person name="Coville G.J."/>
<person name="Culley K.M."/>
<person name="Dhami P."/>
<person name="Davies J."/>
<person name="Dunn M."/>
<person name="Earthrowl M.E."/>
<person name="Ellington A.E."/>
<person name="Evans K.A."/>
<person name="Faulkner L."/>
<person name="Francis M.D."/>
<person name="Frankish A."/>
<person name="Frankland J."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Ghori M.J."/>
<person name="Gilby L.M."/>
<person name="Gillson C.J."/>
<person name="Glithero R.J."/>
<person name="Grafham D.V."/>
<person name="Grant M."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Griffiths M.N.D."/>
<person name="Hall R."/>
<person name="Halls K.S."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Hart E.A."/>
<person name="Heath P.D."/>
<person name="Heathcott R."/>
<person name="Holmes S.J."/>
<person name="Howden P.J."/>
<person name="Howe K.L."/>
<person name="Howell G.R."/>
<person name="Huckle E."/>
<person name="Humphray S.J."/>
<person name="Humphries M.D."/>
<person name="Hunt A.R."/>
<person name="Johnson C.M."/>
<person name="Joy A.A."/>
<person name="Kay M."/>
<person name="Keenan S.J."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Laird G.K."/>
<person name="Langford C."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Leversha M."/>
<person name="Lloyd C.R."/>
<person name="Lloyd D.M."/>
<person name="Loveland J.E."/>
<person name="Lovell J."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Maslen G.L."/>
<person name="Matthews L."/>
<person name="McCann O.T."/>
<person name="McLaren S.J."/>
<person name="McLay K."/>
<person name="McMurray A."/>
<person name="Moore M.J.F."/>
<person name="Mullikin J.C."/>
<person name="Niblett D."/>
<person name="Nickerson T."/>
<person name="Novik K.L."/>
<person name="Oliver K."/>
<person name="Overton-Larty E.K."/>
<person name="Parker A."/>
<person name="Patel R."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Phillimore B.J.C.T."/>
<person name="Phillips S."/>
<person name="Plumb R.W."/>
<person name="Porter K.M."/>
<person name="Ramsey Y."/>
<person name="Ranby S.A."/>
<person name="Rice C.M."/>
<person name="Ross M.T."/>
<person name="Searle S.M."/>
<person name="Sehra H.K."/>
<person name="Sheridan E."/>
<person name="Skuce C.D."/>
<person name="Smith S."/>
<person name="Smith M."/>
<person name="Spraggon L."/>
<person name="Squares S.L."/>
<person name="Steward C.A."/>
<person name="Sycamore N."/>
<person name="Tamlyn-Hall G."/>
<person name="Tester J."/>
<person name="Theaker A.J."/>
<person name="Thomas D.W."/>
<person name="Thorpe A."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Tubby B."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="West A.P."/>
<person name="White S.S."/>
<person name="Whitehead S.L."/>
<person name="Whittaker H."/>
<person name="Wild A."/>
<person name="Willey D.J."/>
<person name="Wilmer T.E."/>
<person name="Wood J.M."/>
<person name="Wray P.W."/>
<person name="Wyatt J.C."/>
<person name="Young L."/>
<person name="Younger R.M."/>
<person name="Bentley D.R."/>
<person name="Coulson A."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Sulston J.E."/>
<person name="Dunham I."/>
<person name="Rogers J."/>
<person name="Beck S."/>
</authorList>
<dbReference type="PubMed" id="14574404"/>
<dbReference type="DOI" id="10.1038/nature02055"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<scope>VARIANT GLU-107</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2003" name="Dev. Cell" volume="4" first="813" last="826">
<title>Prophase destruction of Emi1 by the SCF(betaTrCP/Slimb) ubiquitin ligase activates the anaphase promoting complex to allow progression beyond prometaphase.</title>
<authorList>
<person name="Margottin-Goguet F."/>
<person name="Hsu J.Y."/>
<person name="Loktev A."/>
<person name="Hsieh H.-M."/>
<person name="Reimann J.D.R."/>
<person name="Jackson P.K."/>
</authorList>
<dbReference type="PubMed" id="12791267"/>
<dbReference type="DOI" id="10.1016/s1534-5807(03)00153-9"/>
</citation>
<scope>INTERACTION WITH BTRC</scope>
<scope>PHOSPHORYLATION</scope>
<scope>DEGRADATION</scope>
<scope>MUTAGENESIS OF SER-145; SER-149 AND SER-182</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Mol. Biol. Cell" volume="15" first="5623" last="5634">
<title>Plk1 regulates activation of the anaphase promoting complex by phosphorylating and triggering SCFbetaTrCP-dependent destruction of the APC inhibitor Emi1.</title>
<authorList>
<person name="Hansen D.V."/>
<person name="Loktev A.V."/>
<person name="Ban K.H."/>
<person name="Jackson P.K."/>
</authorList>
<dbReference type="PubMed" id="15469984"/>
<dbReference type="DOI" id="10.1091/mbc.e04-07-0598"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION</scope>
<scope>UBIQUITINATION</scope>
<scope>MUTAGENESIS OF GLU-143; SER-145; SER-148 AND SER-149</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="Proc. Natl. Acad. Sci. U.S.A." volume="101" first="7937" last="7942">
<title>Role of Polo-like kinase in the degradation of early mitotic inhibitor 1, a regulator of the anaphase promoting complex/cyclosome.</title>
<authorList>
<person name="Moshe Y."/>
<person name="Boulaire J."/>
<person name="Pagano M."/>
<person name="Hershko A."/>
</authorList>
<dbReference type="PubMed" id="15148369"/>
<dbReference type="DOI" id="10.1073/pnas.0402442101"/>
</citation>
<scope>PHOSPHORYLATION</scope>
<scope>UBIQUITINATION</scope>
<scope>MUTAGENESIS OF SER-145 AND SER-149</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2006" name="Cell" volume="124" first="367" last="380">
<title>The evi5 oncogene regulates cyclin accumulation by stabilizing the anaphase-promoting complex inhibitor emi1.</title>
<authorList>
<person name="Eldridge A.G."/>
<person name="Loktev A.V."/>
<person name="Hansen D.V."/>
<person name="Verschuren E.W."/>
<person name="Reimann J.D.R."/>
<person name="Jackson P.K."/>
</authorList>
<dbReference type="PubMed" id="16439210"/>
<dbReference type="DOI" id="10.1016/j.cell.2005.10.038"/>
</citation>
<scope>INTERACTION WITH EVI5</scope>
<scope>MUTAGENESIS OF 210-LYS--ASP-216</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2006" name="Genes Dev." volume="20" first="2410" last="2420">
<title>Emi1 stably binds and inhibits the anaphase-promoting complex/cyclosome as a pseudosubstrate inhibitor.</title>
<authorList>
<person name="Miller J.J."/>
<person name="Summers M.K."/>
<person name="Hansen D.V."/>
<person name="Nachury M.V."/>
<person name="Lehman N.L."/>
<person name="Loktev A."/>
<person name="Jackson P.K."/>
</authorList>
<dbReference type="PubMed" id="16921029"/>
<dbReference type="DOI" id="10.1101/gad.1454006"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF CYS-401</scope>
<scope>INTERACTION WITH APC AND FZR1</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2007" name="Genes Dev." volume="21" first="184" last="194">
<title>The APC/C inhibitor, Emi1, is essential for prevention of rereplication.</title>
<authorList>
<person name="Machida Y.J."/>
<person name="Dutta A."/>
</authorList>
<dbReference type="PubMed" id="17234884"/>
<dbReference type="DOI" id="10.1101/gad.1495007"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2007" name="J. Cell Biol." volume="177" first="425" last="437">
<title>Emi1 is needed to couple DNA replication with mitosis but does not regulate activation of the mitotic APC/C.</title>
<authorList>
<person name="Di Fiore B."/>
<person name="Pines J."/>
</authorList>
<dbReference type="PubMed" id="17485488"/>
<dbReference type="DOI" id="10.1083/jcb.200611166"/>
</citation>
<scope>INDUCTION</scope>
<scope>MUTAGENESIS OF ASP-144; SER-145; GLY-146 AND SER-149</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2007" name="Mol. Cell. Biol." volume="27" first="7955" last="7965">
<title>Loss of Emi1-dependent anaphase-promoting complex/cyclosome inhibition deregulates E2F target expression and elicits DNA damage-induced senescence.</title>
<authorList>
<person name="Verschuren E.W."/>
<person name="Ban K.H."/>
<person name="Masek M.A."/>
<person name="Lehman N.L."/>
<person name="Jackson P.K."/>
</authorList>
<dbReference type="PubMed" id="17875940"/>
<dbReference type="DOI" id="10.1128/mcb.00908-07"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2009" name="Mol. Biol. Cell" volume="20" first="1891" last="1902">
<title>DNA damage triggers p21WAF1-dependent Emi1 down-regulation that maintains G2 arrest.</title>
<authorList>
<person name="Lee J."/>
<person name="Kim J.A."/>
<person name="Barbier V."/>
<person name="Fotedar A."/>
<person name="Fotedar R."/>
</authorList>
<dbReference type="PubMed" id="19211842"/>
<dbReference type="DOI" id="10.1091/mbc.e08-08-0818"/>
</citation>
<scope>INDUCTION</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="2013" name="Nat. Cell Biol." volume="15" first="797" last="806">
<title>Emi1 preferentially inhibits ubiquitin chain elongation by the anaphase-promoting complex.</title>
<authorList>
<person name="Wang W."/>
<person name="Kirschner M.W."/>
</authorList>
<dbReference type="PubMed" id="23708001"/>
<dbReference type="DOI" id="10.1038/ncb2755"/>
</citation>
<scope>INTERACTION WITH ANAPC2; CDC23; CDC27; GMNN; UBE2S AND FZR1</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF 322-ARG--LEU-325; CYS-401; CYS-406 AND 444-LEU-ARG-445</scope>
<scope>REGION</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-102</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="19">
<citation type="journal article" date="2018" name="Biomed. Res. Int." volume="2018" first="7849294" last="7849294">
<title>Two Transcripts of FBXO5 Promote Migration and Osteogenic Differentiation of Human Periodontal Ligament Mesenchymal Stem Cells.</title>
<authorList>
<person name="Liu L."/>
<person name="Liu K."/>
<person name="Yan Y."/>
<person name="Chu Z."/>
<person name="Tang Y."/>
<person name="Tang C."/>
</authorList>
<dbReference type="PubMed" id="29850565"/>
<dbReference type="DOI" id="10.1155/2018/7849294"/>
</citation>
<scope>INDUCTION</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2018" name="Nature" volume="558" first="313" last="317">
<title>EMI1 switches from being a substrate to an inhibitor of APC/CCDH1 to start the cell cycle.</title>
<authorList>
<person name="Cappell S.D."/>
<person name="Mark K.G."/>
<person name="Garbett D."/>
<person name="Pack L.R."/>
<person name="Rape M."/>
<person name="Meyer T."/>
</authorList>
<dbReference type="PubMed" id="29875408"/>
<dbReference type="DOI" id="10.1038/s41586-018-0199-7"/>
</citation>
<scope>FUNCTION</scope>
<scope>INDUCTION</scope>
<scope>MUTAGENESIS OF CYS-401</scope>
<scope>UBIQUITINATION</scope>
</reference>
<reference key="21" evidence="1">
<citation type="journal article" date="2013" name="Nat. Struct. Mol. Biol." volume="20" first="827" last="835">
<title>Electron microscopy structure of human APC/C(CDH1)-EMI1 reveals multimodal mechanism of E3 ligase shutdown.</title>
<authorList>
<person name="Frye J.J."/>
<person name="Brown N.G."/>
<person name="Petzold G."/>
<person name="Watson E.R."/>
<person name="Grace C.R."/>
<person name="Nourse A."/>
<person name="Jarvis M.A."/>
<person name="Kriwacki R.W."/>
<person name="Peters J.M."/>
<person name="Stark H."/>
<person name="Schulman B.A."/>
</authorList>
<dbReference type="PubMed" id="23708605"/>
<dbReference type="DOI" id="10.1038/nsmb.2593"/>
</citation>
<scope>STRUCTURE BY NMR OF 364-447</scope>
<scope>STRUCTURE BY ELECTRON MICROSCOPY WITH APC COMPLEX</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF 322-ARG--LEU-325; 339-LYS--LEU-345; LEU-345; 346-SER--THR-355; 356-TYR--ARG-358; TYR-356; ARG-358; LEU-375; LYS-376; ARG-393 AND CYS-409</scope>
<scope>REGION</scope>
</reference>
<reference key="22" evidence="2">
<citation type="journal article" date="2015" name="Nature" volume="522" first="450" last="454">
<title>Atomic structure of the APC/C and its mechanism of protein ubiquitination.</title>
<authorList>
<person name="Chang L."/>
<person name="Zhang Z."/>
<person name="Yang J."/>
<person name="McLaughlin S.H."/>
<person name="Barford D."/>
</authorList>
<dbReference type="PubMed" id="26083744"/>
<dbReference type="DOI" id="10.1038/nature14471"/>
</citation>
<scope>STRUCTURE BY ELECTRON MICROSCOPY (3.60 ANGSTROMS) OF 1-447 AND 1-23 IN COMPLEX WITH APC</scope>
<scope>SUBUNIT</scope>
</reference>
<comment type="function">
<text evidence="4 13 14 15 16 18 19 21 22">Regulator of APC activity during mitotic and meiotic cell cycle (PubMed:17485488, PubMed:17234884, PubMed:17875940, PubMed:23708001, PubMed:23708605, PubMed:16921029). During mitotic cell cycle plays a role as both substrate and inhibitor of APC-FZR1 complex (PubMed:29875408, PubMed:17485488, PubMed:17234884, PubMed:17875940, PubMed:23708001, PubMed:23708605, PubMed:16921029). During G1 phase, plays a role as substrate of APC-FZR1 complex E3 ligase (PubMed:29875408). Then switches as an inhibitor of APC-FZR1 complex during S and G2 leading to cell-cycle commitment (PubMed:29875408). As APC inhibitor, prevents the degradation of APC substrates at multiple levels: by interacting with APC and blocking access of APC substrates to the D-box coreceptor, formed by FZR1 and ANAPC10; by suppressing ubiquitin ligation and chain elongation by APC by preventing the UBE2C and UBE2S activities (PubMed:23708605, PubMed:23708001, PubMed:16921029). Plays a role in genome integrity preservation by coordinating DNA replication with mitosis through APC inhibition in interphase to stabilize CCNA2 and GMNN in order to promote mitosis and prevent rereplication and DNA damage-induced cellular senescence (PubMed:17234884, PubMed:17485488, PubMed:17875940). During oocyte maturation, plays a role in meiosis through inactivation of APC-FZR1 complex. Inhibits APC through RPS6KA2 interaction that increases FBXO5 affiniy for CDC20 leading to the metaphase arrest of the second meiotic division before fertilization (By similarity). Controls entry into the first meiotic division through inactivation of APC-FZR1 complex (By similarity). Promotes migration and osteogenic differentiation of mesenchymal stem cells (PubMed:29850565).</text>
</comment>
<comment type="pathway">
<text>Protein modification; protein ubiquitination.</text>
</comment>
<comment type="subunit">
<text evidence="4 6 7 12 18 20">Part of a SCF (SKP1-cullin-F-box) protein ligase complex (By similarity). Interacts with BTRC; mediates proteolysis by the SCF ubiquitin ligase complex leading to activation of APC in late mitosis and subsequent mitotic progression (PubMed:12791267). Interacts with FZR1/CDH1 and the N-terminal substrate-binding domain of CDC20; prevents APC activation (PubMed:11988738). Also interacts with EVI5 which blocks its phosphorylation by PLK1 and prevents its subsequent binding to BTRC and degradation (PubMed:16439210). Interacts simultaneously with anaphase promoting complex (APC), through at least ANAPC2, CDC23, CDC27, the APC substrate GMNN and the APC activator FZR1 (PubMed:23708001, PubMed:26083744). Interacts with UBE2S; interferes with the activity of UBE2S mainly by disrupting the dynamic electrostatic association between the C-terminal tail of UBE2S and ANAPC2 (PubMed:23708001). Interacts with RPS6KA2; cooperates to induce the metaphase arrest of early blastomeres; increases and stabilizes interaction of FBXO5 with CDC20 (By similarity).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-852298">
<id>Q9UKT4</id>
</interactant>
<interactant intactId="EBI-994813">
<id>P30260</id>
<label>CDC27</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-852298">
<id>Q9UKT4</id>
</interactant>
<interactant intactId="EBI-852291">
<id>O60447</id>
<label>EVI5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-852298">
<id>Q9UKT4</id>
</interactant>
<interactant intactId="EBI-307486">
<id>P63208</id>
<label>SKP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-16059332">
<id>Q9UKT4-1</id>
</interactant>
<interactant intactId="EBI-396211">
<id>Q9UJX6</id>
<label>ANAPC2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="6">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="6">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="10">Cytoplasm</location>
<location evidence="10">Cytoskeleton</location>
<location evidence="10">Spindle</location>
</subcellularLocation>
<text evidence="6 10">In interphase, localizes in a punctate manner in the nucleus and cytoplasm with some perinuclear concentration (PubMed:11988738). In mitotic cells, localizes throughout the cell, particularly at the spindle (PubMed:15469984).</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q9UKT4-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q9UKT4-2</id>
<name>2</name>
<sequence type="described" ref="VSP_041362"/>
</isoform>
</comment>
<comment type="developmental stage">
<text evidence="6">Accumulates in late G1 phase, levels rise during S phase and drop in early mitosis.</text>
</comment>
<comment type="induction">
<text evidence="6 15 17 21 22">Up-regulated at 7 days after osteogenic induction (PubMed:29850565). Down-regulated in late G2 phase or mitosis (PubMed:17485488). Down-regulated in G2 phase after DNA damage in a CDKN1A-dependent manner (PubMed:19211842). Down-regulated in G1 phase when APC-FZR1 complex is active and accumulates at the G1-S transition, coincident with the inactivation of APC-FZR1 complex (PubMed:29875408). At the G1-S transition, transcriptionally induced by the E2F transcription factor (PubMed:11988738).</text>
</comment>
<comment type="PTM">
<text evidence="4 7 10">Phosphorylation by CDK2 and subsequently by PLK1 triggers degradation during early mitosis through ubiquitin-mediated proteolysis by the SCF ubiquitin ligase complex containing the F-box protein BTRC. This degradation is necessary for the activation of APC in late mitosis and subsequent mitotic progression (PubMed:12791267, PubMed:15469984). Phosphorylated by RPS6KA2; increases and stabilizes interaction with CDC20 (By similarity).</text>
</comment>
<comment type="PTM">
<text evidence="4 10 22">Ubiquitinated by the SCF(BTRC) complex following phosphorylation by PLK1 (PubMed:15469984). Undergoes both 'Lys-11' and 'Lys-48'-linked polyubiquitination by APC-FZR1 complex leading to degradation by proteasome during G1 phase (PubMed:29875408). Degraded through the SCF(BTRC) complex; degradation occurs during oocyte maturation, between germinal vesicle breakdown (GVBD) and meiosis I, and is required for the meiosis I-meiosis II transition (By similarity).</text>
</comment>
<dbReference type="EMBL" id="AF129535">
<property type="protein sequence ID" value="AAF04469.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY079515">
<property type="protein sequence ID" value="AAL86610.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK055221">
<property type="protein sequence ID" value="BAG51487.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL080276">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471051">
<property type="protein sequence ID" value="EAW47719.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC018905">
<property type="protein sequence ID" value="AAH18905.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS47501.1">
<molecule id="Q9UKT4-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS5242.1">
<molecule id="Q9UKT4-1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001135994.1">
<molecule id="Q9UKT4-2"/>
<property type="nucleotide sequence ID" value="NM_001142522.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_036309.1">
<molecule id="Q9UKT4-1"/>
<property type="nucleotide sequence ID" value="NM_012177.4"/>
</dbReference>
<dbReference type="PDB" id="2M6N">
<property type="method" value="NMR"/>
<property type="chains" value="A=364-447"/>
</dbReference>
<dbReference type="PDB" id="4UI9">
<property type="method" value="EM"/>
<property type="resolution" value="3.60"/>
<property type="chains" value="S=1-447, U=1-27"/>
</dbReference>
<dbReference type="PDBsum" id="2M6N"/>
<dbReference type="PDBsum" id="4UI9"/>
<dbReference type="BMRB" id="Q9UKT4"/>
<dbReference type="SMR" id="Q9UKT4"/>
<dbReference type="BioGRID" id="117655">
<property type="interactions" value="42"/>
</dbReference>
<dbReference type="DIP" id="DIP-38023N"/>
<dbReference type="ELM" id="Q9UKT4"/>
<dbReference type="IntAct" id="Q9UKT4">
<property type="interactions" value="24"/>
</dbReference>
<dbReference type="MINT" id="Q9UKT4"/>
<dbReference type="STRING" id="9606.ENSP00000229758"/>
<dbReference type="iPTMnet" id="Q9UKT4"/>
<dbReference type="PhosphoSitePlus" id="Q9UKT4"/>
<dbReference type="BioMuta" id="FBXO5"/>
<dbReference type="DMDM" id="24636847"/>
<dbReference type="EPD" id="Q9UKT4"/>
<dbReference type="jPOST" id="Q9UKT4"/>
<dbReference type="MassIVE" id="Q9UKT4"/>
<dbReference type="PaxDb" id="Q9UKT4"/>
<dbReference type="PeptideAtlas" id="Q9UKT4"/>
<dbReference type="PRIDE" id="Q9UKT4"/>
<dbReference type="ProteomicsDB" id="84847">
<molecule id="Q9UKT4-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="84848">
<molecule id="Q9UKT4-2"/>
</dbReference>
<dbReference type="Antibodypedia" id="33385">
<property type="antibodies" value="236 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="26271"/>
<dbReference type="Ensembl" id="ENST00000229758">
<molecule id="Q9UKT4-1"/>
<property type="protein sequence ID" value="ENSP00000229758"/>
<property type="gene ID" value="ENSG00000112029"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000367241">
<molecule id="Q9UKT4-2"/>
<property type="protein sequence ID" value="ENSP00000356210"/>
<property type="gene ID" value="ENSG00000112029"/>
</dbReference>
<dbReference type="GeneID" id="26271"/>
<dbReference type="KEGG" id="hsa:26271"/>
<dbReference type="UCSC" id="uc003qpg.4">
<molecule id="Q9UKT4-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="26271"/>
<dbReference type="DisGeNET" id="26271"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000112029.9"/>
<dbReference type="GeneCards" id="FBXO5"/>
<dbReference type="HGNC" id="HGNC:13584">
<property type="gene designation" value="FBXO5"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000112029">
<property type="expression patterns" value="Group enriched (bone marrow, lymphoid tissue)"/>
</dbReference>
<dbReference type="MIM" id="606013">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q9UKT4"/>
<dbReference type="OpenTargets" id="ENSG00000112029"/>
<dbReference type="PharmGKB" id="PA28045"/>
<dbReference type="eggNOG" id="ENOG502QPWN">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00530000063692"/>
<dbReference type="HOGENOM" id="CLU_055946_0_0_1"/>
<dbReference type="InParanoid" id="Q9UKT4"/>
<dbReference type="KO" id="K10292"/>
<dbReference type="OMA" id="IKFSPHA"/>
<dbReference type="OrthoDB" id="521317at2759"/>
<dbReference type="PhylomeDB" id="Q9UKT4"/>
<dbReference type="TreeFam" id="TF101170"/>
<dbReference type="PathwayCommons" id="Q9UKT4"/>
<dbReference type="Reactome" id="R-HSA-174113">
<property type="pathway name" value="SCF-beta-TrCP mediated degradation of Emi1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-176408">
<property type="pathway name" value="Regulation of APC/C activators between G1/S and early anaphase"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-176417">
<property type="pathway name" value="Phosphorylation of Emi1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-68881">
<property type="pathway name" value="Mitotic Metaphase/Anaphase Transition"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-69205">
<property type="pathway name" value="G1/S-Specific Transcription"/>
</dbReference>
<dbReference type="SIGNOR" id="Q9UKT4"/>
<dbReference type="UniPathway" id="UPA00143"/>
<dbReference type="BioGRID-ORCS" id="26271">
<property type="hits" value="708 hits in 885 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="FBXO5">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="FBXO5"/>
<dbReference type="GenomeRNAi" id="26271"/>
<dbReference type="Pharos" id="Q9UKT4">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q9UKT4"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 6"/>
</dbReference>
<dbReference type="RNAct" id="Q9UKT4">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000112029">
<property type="expression patterns" value="Expressed in ventricular zone and 184 other tissues"/>
</dbReference>
<dbReference type="Genevisible" id="Q9UKT4">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0072687">
<property type="term" value="C:meiotic spindle"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005819">
<property type="term" value="C:spindle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010997">
<property type="term" value="F:anaphase-promoting complex binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046872">
<property type="term" value="F:metal ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0019901">
<property type="term" value="F:protein kinase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1990948">
<property type="term" value="F:ubiquitin ligase inhibitor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031145">
<property type="term" value="P:anaphase-promoting complex-dependent catabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0051301">
<property type="term" value="P:cell division"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0046785">
<property type="term" value="P:microtubule polymerization"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:2000773">
<property type="term" value="P:negative regulation of cellular senescence"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032876">
<property type="term" value="P:negative regulation of DNA endoreduplication"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045835">
<property type="term" value="P:negative regulation of meiotic nuclear division"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0045841">
<property type="term" value="P:negative regulation of mitotic metaphase/anaphase transition"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2001021">
<property type="term" value="P:negative regulation of response to DNA damage stimulus"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1904667">
<property type="term" value="P:negative regulation of ubiquitin protein ligase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051444">
<property type="term" value="P:negative regulation of ubiquitin-protein transferase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001556">
<property type="term" value="P:oocyte maturation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070169">
<property type="term" value="P:positive regulation of biomineral tissue development"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008284">
<property type="term" value="P:positive regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010971">
<property type="term" value="P:positive regulation of G2/M transition of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1905322">
<property type="term" value="P:positive regulation of mesenchymal stem cell migration"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045669">
<property type="term" value="P:positive regulation of osteoblast differentiation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016567">
<property type="term" value="P:protein ubiquitination"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-UniPathway"/>
</dbReference>
<dbReference type="GO" id="GO:0006275">
<property type="term" value="P:regulation of DNA replication"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007346">
<property type="term" value="P:regulation of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1901990">
<property type="term" value="P:regulation of mitotic cell cycle phase transition"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007088">
<property type="term" value="P:regulation of mitotic nuclear division"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0000083">
<property type="term" value="P:regulation of transcription involved in G1/S transition of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007057">
<property type="term" value="P:spindle assembly involved in female meiosis I"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016050">
<property type="term" value="P:vesicle organization"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="DisProt" id="DP01450"/>
<dbReference type="InterPro" id="IPR001810">
<property type="entry name" value="F-box_dom"/>
</dbReference>
<dbReference type="Pfam" id="PF00646">
<property type="entry name" value="F-box"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51872">
<property type="entry name" value="ZF_ZBR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0131">Cell cycle</keyword>
<keyword id="KW-0132">Cell division</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0206">Cytoskeleton</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0498">Mitosis</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0833">Ubl conjugation pathway</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="chain" description="F-box only protein 5" id="PRO_0000119881">
<location>
<begin position="1"/>
<end position="447"/>
</location>
</feature>
<feature type="domain" description="F-box">
<location>
<begin position="250"/>
<end position="296"/>
</location>
</feature>
<feature type="zinc finger region" description="ZBR-type" evidence="5">
<location>
<begin position="374"/>
<end position="422"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with EVI5" evidence="12">
<location>
<begin position="135"/>
<end position="244"/>
</location>
</feature>
<feature type="region of interest" description="Requires for efficient binding to CDC20" evidence="4">
<location>
<begin position="261"/>
<end position="409"/>
</location>
</feature>
<feature type="region of interest" description="Sufficient for interaction with RPS6KA2; Prevents association of CDC20 with RPS6KA2" evidence="4">
<location>
<begin position="261"/>
<end position="339"/>
</location>
</feature>
<feature type="region of interest" description="Inhibits APC ubiquitin ligase activity" evidence="19">
<location>
<begin position="305"/>
<end position="447"/>
</location>
</feature>
<feature type="region of interest" description="Competitively blocks access of APC substrates to the D-box coreceptor formed by FZR1 and ANAPC10" evidence="18">
<location>
<begin position="322"/>
<end position="325"/>
</location>
</feature>
<feature type="region of interest" description="Allows a rapid multiple mono-ubiquitination of the APC substrate, but strongly inhibits the slow ubiquitin chain elongation catalyzed by UBCH10" evidence="18">
<location>
<begin position="378"/>
<end position="420"/>
</location>
</feature>
<feature type="region of interest" description="Sufficient to suppress UBE2S activity; essential for interaction with UBE2S; competitively inhibits the rapide ubiquitin chain elongation by UBE2D1 which blocks UBE2D1 with APC; indispensable for recruitment and position of FBXO5 to the catalytic site of APC; abrogates the inhibition of ubiquitin chain assembly primarily catalyzed by UBE2S; inhibits the ubiquitination by either UBE2C or UBE2D1" evidence="18">
<location>
<begin position="437"/>
<end position="447"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="94"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="102"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_041362" evidence="24">
<location>
<begin position="1"/>
<end position="46"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2073260." id="VAR_024440" evidence="8 11">
<original>Q</original>
<variation>E</variation>
<location>
<position position="107"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs7763565." id="VAR_049038">
<original>L</original>
<variation>F</variation>
<location>
<position position="164"/>
</location>
</feature>
<feature type="mutagenesis site" description="Delays degradation." evidence="10">
<original>E</original>
<variation>A</variation>
<location>
<position position="143"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect protein stability." evidence="15">
<original>D</original>
<variation>A</variation>
<location>
<position position="144"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect protein stability; when associated with A-149." evidence="15">
<original>S</original>
<variation>A</variation>
<location>
<position position="145"/>
</location>
</feature>
<feature type="mutagenesis site" description="Degraded in similar manner to wild-type." evidence="7 9 10">
<original>S</original>
<variation>E</variation>
<location>
<position position="145"/>
</location>
</feature>
<feature type="mutagenesis site" description="Not mitotically degraded. Shows impaired interaction with BTRC and reduced phosphate incorporation; when associated with N-149." evidence="7 9 10">
<original>S</original>
<variation>N</variation>
<location>
<position position="145"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect protein stability." evidence="15">
<original>G</original>
<variation>V</variation>
<location>
<position position="146"/>
</location>
</feature>
<feature type="mutagenesis site" description="Degraded in similar manner to wild-type." evidence="10">
<original>S</original>
<variation>A</variation>
<location>
<position position="148"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect protein stability; when associated with A-145." evidence="15">
<original>S</original>
<variation>A</variation>
<location>
<position position="149"/>
</location>
</feature>
<feature type="mutagenesis site" description="Degraded in similar manner to wild-type." evidence="7 9 10">
<original>S</original>
<variation>E</variation>
<location>
<position position="149"/>
</location>
</feature>
<feature type="mutagenesis site" description="Not mitotically degraded. Shows impaired interaction with BTRC and reduced phosphate incorporation; when associated with N-145." evidence="7 9 10">
<original>S</original>
<variation>N</variation>
<location>
<position position="149"/>
</location>
</feature>
<feature type="mutagenesis site" description="Shows impaired interaction with BTRC." evidence="7">
<original>S</original>
<variation>A</variation>
<location>
<position position="182"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with EVI5." evidence="12">
<original>KRNPKVD</original>
<variation>AAAAAAA</variation>
<location>
<begin position="210"/>
<end position="216"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect inhibition of UBE2S-catalyzed chain elongation. Efficiently inhibits the degradation of PTTG1 at relatively high concentration. Reduces the competitive ability of FBXO5 to inhibit the association of PTTG1 to APC. Can not compete with the APC substrate for APC binding. Decreases inhibition of CCNB1 ubiquitination by UBE2C." evidence="18 19">
<original>RTPL</original>
<variation>ATPA</variation>
<location>
<begin position="322"/>
<end position="325"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs CCNB1 ubiquitination by UBE2C; when associated with 356-Y--R-358 del." evidence="19">
<location>
<begin position="339"/>
<end position="345"/>
</location>
</feature>
<feature type="mutagenesis site" description="Substantially impairs inhibition of CCNB1 ubiquitination by UBE2C; when associated with 346-S--T-355 del." evidence="19">
<original>L</original>
<variation>A</variation>
<location>
<position position="345"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits CCNB1 ubiquitination by UBE2C. Substantially impairs inhibition of CCNB1 ubiquitination by UBE2C; when associated with A-345; A-356 and A-358." evidence="19">
<location>
<begin position="346"/>
<end position="355"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs CCNB1 ubiquitination by UBE2C; when associated with 339-K--L-345 del." evidence="19">
<location>
<begin position="356"/>
<end position="358"/>
</location>
</feature>
<feature type="mutagenesis site" description="Substantially impairs inhibition of CCNB1 ubiquitination by UBE2C; when associated with 346-S--T-355 del." evidence="19">
<original>Y</original>
<variation>A</variation>
<location>
<position position="356"/>
</location>
</feature>
<feature type="mutagenesis site" description="Substantially impairs inhibition of CCNB1 ubiquitination by UBE2C; when associated with 346-S--T-355 del." evidence="19">
<original>R</original>
<variation>A</variation>
<location>
<position position="358"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases UBE2C-mediated ubiquitination." evidence="19">
<original>L</original>
<variation>A</variation>
<location>
<position position="375"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases UBE2C-mediated ubiquitination." evidence="19">
<original>K</original>
<variation>A</variation>
<location>
<position position="376"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases UBE2C-mediated ubiquitination." evidence="19">
<original>R</original>
<variation>A</variation>
<location>
<position position="393"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced inhibition of APC. Does not affect the FBXO5-mediated inhibitory activity against ubiquitin chain assembly. Does not affect the FBXO5-mediated inhibitory activity against ubiquitin chain assembly; when associated with S-401. Does not affect inhibition of UBE2S-catalyzed chain elongation. Reduces the competitive ability of FBXO5 to inhibit the association of securin to APC. Can still compete with the APC substrate for APC binding. Fails to inhibit ubiquitin chain assembly by UBE2C or mono-ubiquitination by UBE2D1. Largely abolishes the inhibitory activity against protein degradation. Fails to inactivate APC-FZR1 complex. Allows FBXO5 degradation in the absence of CDK4 inhibitor." evidence="13 18 22">
<original>C</original>
<variation>S</variation>
<location>
<position position="401"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect the inhibitory activity against chain assembly; when associated with S-401." evidence="18">
<original>C</original>
<variation>S</variation>
<location>
<position position="406"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases UBE2C-mediated ubiquitination." evidence="19">
<original>C</original>
<variation>A</variation>
<location>
<position position="409"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loses inhibitory activity on UBE2S-catalyzed chain elongation." evidence="18">
<original>LR</original>
<variation>AA</variation>
<location>
<begin position="444"/>
<end position="445"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; BAG51487." ref="3" evidence="26">
<original>N</original>
<variation>D</variation>
<location>
<position position="212"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="379"/>
<end position="381"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="384"/>
<end position="388"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="389"/>
<end position="392"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="393"/>
<end position="396"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="404"/>
<end position="406"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="407"/>
<end position="409"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="410"/>
<end position="412"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2M6N"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4UI9"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q7TSG3"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU01220"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11988738"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12791267"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15148369"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15469984"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16439210"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16921029"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17234884"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17485488"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17875940"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19211842"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23708001"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23708605"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26083744"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29850565"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29875408"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="11988738"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15148369"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000305"/>
<evidence key="27" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:13584"/>
</source>
</evidence>
<sequence length="447" mass="50146" checksum="196FBC2578F92120" modified="2000-05-01" version="1">MSRRPCSCALRPPRCSCSASPSAVTAAGRPRPSDSCKEESSTLSVKMKCDFNCNHVHSGLKLVKPDDIGRLVSYTPAYLEGSCKDCIKDYERLSCIGSPIVSPRIVQLETESKRLHNKENQHVQQTLNSTNEIEALETSRLYEDSGYSSFSLQSGLSEHEEGSLLEENFGDSLQSCLLQIQSPDQYPNKNLLPVLHFEKVVCSTLKKNAKRNPKVDREMLKEIIARGNFRLQNIIGRKMGLECVDILSELFRRGLRHVLATILAQLSDMDLINVSKVSTTWKKILEDDKGAFQLYSKAIQRVTENNNKFSPHASTREYVMFRTPLASVQKSAAQTSLKKDAQTKLSNQGDQKGSTYSRHNEFSEVAKTLKKNESLKACIRCNSPAKYDCYLQRATCKREGCGFDYCTKCLCNYHTTKDCSDGKLLKASCKIGPLPGTKKSKKNLRRL</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

